| Literature DB >> 28386228 |
Mingzhen Li1, Peng Xu2, Yanhua Xu3, Huajing Teng4, Weiping Tian3, Quansheng Du5, Mei Zhao6.
Abstract
Prefrontal cortex (PFC)-dependent functions, such as executive function, explicit learning, and memory, are negatively affected in cocaine abusers and experimental animal models of cocaine treatment. However, its molecular mechanisms are less understood. In the present study, we performed transcriptome profiling of the dynamic changes in the PFC after repeated cocaine administration in mice. We found 463, 14, and 535 differentially expressed genes (DEGs) at 2 h, 24 h, and 7 days, respectively, after the withdrawal of chronic cocaine treatment. Time-series correlation analysis identified 5 clusters of statistically significant expression patterns. The expression levels of DEGs in Clusters 1 and 5 exhibited a gradual or fluctuant decrease, Cluster 2 exhibited an initial increase followed by a decrease or return to the baseline level, and Clusters 3 and 4 exhibited a fluctuant increase in the expression of DEGs. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that genes related to oxidative phosphorylation, ribosomes, and neurodegenerative disorder were enriched in Cluster 1; genes related to the mitogen activated protein kinase (MAPK), transforming growth factor (TGF)-β, insulin signaling, and circadian pathways were enriched in Cluster 2; genes related to plasticity-related pathways were enriched in Clusters 3 and 4; and genes related to the proteasome were enriched in Cluster 5. Our results suggest that maladaptive neural plasticity associated with psychostimulant dependence may be an ongoing degenerative process with dynamic changes in the gene network at different stages of withdrawal. Furthermore, it could be helpful to develop new therapeutic approaches according to different periods of abstinence.Entities:
Keywords: addiction; cocaine; prefrontal cortex (PFC); transcriptome; withdrawal
Year: 2017 PMID: 28386228 PMCID: PMC5362609 DOI: 10.3389/fphar.2017.00142
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Venn map of DEGs from different withdrawal time: subsets of significant changes by Tukey's HSD comparison. The numbers within each segment indicate the number of DEGs of different withdrawal time points.
Distinct pathways involved in different stages of withdrawal after chronic cocaine treatment.
| 1 | Pathways in cancer | 0.005854 | ko05200 |
| 2 | Circadian rhythm - mammal | 0.005854 | ko04710 |
| 3 | Adherens junction | 0.006437 | ko04520 |
| 4 | Circadian rhythm - fly | 0.011379 | ko04711 |
| 5 | Jak-STAT signaling pathway | 0.011575 | ko04630 |
| 6 | Melanogenesis | 0.029236 | ko04916 |
| 7 | Wnt signaling pathway | 0.029236 | ko04310 |
| 8 | MAPK signaling pathway | 0.029236 | ko04010 |
| # | Pathway | FDR | Pathway ID |
| 1 | Circadian rhythm - mammal | 0.00279 | ko04710 |
| 2 | MAPK signaling pathway | 0.013751 | ko04010 |
| 3 | Circadian rhythm - fly | 0.030747 | ko04711 |
| # | Pathway | FDR | Pathway ID |
| 1 | Oxidative phosphorylation | 4.86E-32 | ko00190 |
| 2 | Ribosome | 3.71E-31 | ko03010 |
| 3 | Parkinson's disease | 5.02E-27 | ko05012 |
| 4 | Huntington's disease | 1.70E-26 | ko05016 |
| 5 | Alzheimer's disease | 2.96E-24 | ko05010 |
| 6 | Proteasome | 2.00E-07 | ko03050 |
| 7 | Cardiac muscle contraction | 3.95E-06 | ko04260 |
| 8 | Vibrio cholerae infection | 2.19E-05 | ko05110 |
| 9 | Metabolic pathways | 2.63E-05 | ko01100 |
| 10 | Rheumatoid arthritis | 0.001783 | ko05323 |
| 11 | Epithelial cell signaling in Helicobacter pylori infection | 0.001876 | ko05120 |
| 12 | Collecting duct acid secretion | 0.004512 | ko04966 |
| 13 | RNA polymerase | 0.007616 | ko03020 |
| 14 | Citrate cycle (TCA cycle) | 0.008566 | ko00020 |
| 15 | Protein export | 0.009591 | ko03060 |
| 16 | Gastric acid secretion | 0.011006 | ko04971 |
| 17 | Salivary secretion | 0.015994 | ko04970 |
| 18 | Vascular smooth muscle contraction | 0.016231 | ko04270 |
| 19 | Aldosterone-regulated sodium reabsorption | 0.028328 | ko04960 |
| 20 | Long-term potentiation | 0.035467 | ko04720 |
*FDR mean “false discovery rate.”
Figure 2Correlated expression Clusters and their sub-clusters discovered using the short time series expression miner (STEM) algorithm for time series profile matching: (A): Cluster 1 and its sub-cluster; (B): Cluster 2 and its sub-cluster; (C): Cluster 3 and its sub-cluster; (D): Cluster 4 and its sub-cluster; (E): Cluster 5 and its sub-cluster. Different colors within each sub-cluster represented different genes. Values are the mean Log2(fold change) values as compared to sacrifice-time matched control animals.
Figure 3Functional annotation of DEGs of Time series clusters by KEGG pathways. (A) Functional annotation of DEGs of cluster 1; (B): Functional annotation of DEGs of cluster 2; (C): Functional annotation of DEGs of cluster 3; (D): Functional annotation of DEGs of cluster 4; (E): Functional annotation of DEGs of cluster 5. The length of the bar represent the number of gene involved in the pathway.
Comparison of RNA-seq and RT-PCR.
| 5.4 | 1.67 | 1.38 | 3.70 | 1.37 | 1.66 | |
| 4.53 | 1.62 | 1.51 | 4.37 | 2.36 | 1.29 | |
| 2.03 | 1.7 | 1.32 | 1.40 | 1.26 | 1.36 | |
| 3.01 | 1.69 | 1.18 | 2.10 | 1.14 | 0.99 | |
| 1.00 | 1.17 | 1.18 | 1.16 | 1.17 | 1.31 | |
| 1.36 | 1.07 | 1.22 | 1.01 | 0.87 | 1.18 | |
| 1.43 | 0.92 | 1.33 | 0.88 | 0.81 | 1.01 | |
| 1.33 | 1.23 | 1.14 | 1.08 | 1.07 | 0.84 | |
| 1.03 | 1.004 | 1.005 | 0.69 | 0.95 | 0.73 | |
| 1.09 | 0.96 | 1.38 | 0.92 | 0.83 | 1.25 | |
p < 0.05 compared with saline control.
DEGs involved in the MAPK signal pathway.
| 2 h | A.S./Receptor | – | – | |
| MAPKKK | – | – | ||
| MAPKK | – | – | Crk1 | |
| MAPK/MAPK Phosphatase | Dusp1, Dusp4, Dusp5, Dusp6 | p38/Dusp1, Dusp4, Dusp5, Dusp6 | Dusp1, Dusp4, Dusp5, Dusp6 | |
| Downstream effectors | Mknk2, Rps6ka2, Fos, Nr4a1 | Hsp27 | – | |
| 24 h | A.S./Receptor | – | – | – |
| MAPKKK | – | – | – | |
| MAPKK | – | – | – | |
| MAPK/MAPK Phosphatase | Dusp6 | Dusp6 | Dusp6 | |
| Downstream effectors | Fos, Nr4a1 | – | – | |
| 7 d | A.S./Receptor | Fgfr3 | – | – |
| MAPKKK | Prkcb (PKC) | – | – | |
| MAPKK | – | – | – | |
| MAPK/MAPK Phosphatase | Dusp1, Dusp6 | Dusp1, Dusp6 | Dusp1, Dusp6 | |
| Downstream effectors | Stmn1, Fos, Nr4a1 | – | – |